Xiao-Xiao Dinglin
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Lung Cancer Treatments and Mutations
Papers in
-
- Lung Cancer Treatments and Mutations 3
- Brain Metastases and Treatment 2
-
- RNA modifications and cancer 4
- Circular RNAs in diseases 3
- Co-authors
- Herui Yao (10 shared papers)Qian Hu (3 shared papers)Hai Hu (3 shared papers)Qingjian Li (3 shared papers)Xiaorong Lin (2 shared papers)Xiaoding Xu (2 shared papers)Xue Hou (3 shared papers)Xing Yang (3 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Cancer Research (1 paper)Advanced Science (1 paper)Cell Reports (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- China
In The Last Decade
Xiao-Xiao Dinglin
15 papers receiving 433 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 193
- Pulmonary and Respiratory Medicine 107
- Molecular Biology 234
- Oncology 84
- Genetics 10
Countries citing papers authored by Xiao-Xiao Dinglin
This map shows the geographic impact of Xiao-Xiao Dinglin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Xiao Dinglin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Xiao Dinglin more than expected).
Fields of papers citing papers by Xiao-Xiao Dinglin
This network shows the impact of papers produced by Xiao-Xiao Dinglin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Xiao Dinglin. The network helps show where Xiao-Xiao Dinglin may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao-Xiao Dinglin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 106 | |
| 2 | 2020 | 75 | |
| 3 | 2020 | 67 | |
| 4 | 2017 | 66 | |
| 5 | miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1. | 2017 | 55 |
| 6 | 2017 | 23 | |
| 7 | 2020 | 11 | |
| 8 | 2020 | 7 | |
| 9 | 2016 | 6 | |
| 10 | 2021 | 5 | |
| 11 | 2023 | 4 | |
| 12 | 2015 | 4 | |
| 13 | 2014 | 3 | |
| 14 | 2025 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2025 | 0 |
About Xiao-Xiao Dinglin
Xiao-Xiao Dinglin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 16 papers that have together received 434 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers), Lung Cancer Treatments and Mutations (3 papers), HER2/EGFR in Cancer Research (3 papers), Circular RNAs in diseases (3 papers), Brain Metastases and Treatment (2 papers), MicroRNA in disease regulation (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Cancer Research (193 citations), Pulmonary and Respiratory Medicine (107 citations), Molecular Biology (234 citations), Oncology (84 citations) and Genetics (10 citations). Xiao-Xiao Dinglin has collaborated with scholars based in China. Frequent co-authors include Herui Yao, Qian Hu, Hai Hu, Qingjian Li, Xiaorong Lin, Xiaoding Xu, Xue Hou, Xing Yang, Yuanyuan Zhao and Xiao Lin. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Advanced Science, Cell Reports and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.